# Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-of-the-mage-a3-cancer-immunotherapeutic-as-adjuvant-therapy-in-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Johan Vansteenkiste,Byoung Chul Cho,Tõnu Vanakesa,Tommaso De Pas,M. Zieliński,Moon Soo Kim,Jacek Jassem,Masahiro Yoshimura,Jubrail Dahabreh,Haruhiku Nakayama,Libor Havel,Haruhiko Kondo,Tetsuya Mitsudomi,Paul Zarogoulidis,Oleg Gladkov,Katalin Udud,Hirohito Tada,Hans Hoffman,Anders Bugge,Paul Taylor,Emilio Esteban Gonzalez,Mei Lin Liao,Jianxing He,Jean-Louis Pujol,Jamila Louahed,Muriel Debois,Vincent Brichard,C. Debruyne,Patrick Therasse,Nasser K. Altorki |
| Citations | 500 |
| DOI | 10.1016/s1470-2045(16)00099-1 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://hdl.handle.net/10651/39536 |
| OpenAlex ID | https://openalex.org/W2344034377 |
| PMID | 27132212 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Tommaso De Pas](https://scholariq.org/researchers/tommaso-de-pas/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

## Paper topics

- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lymphadenopathy Diagnosis and Analysis](https://scholariq.org/topics/lymphadenopathy-diagnosis-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.